4Vote!
PR News Wire (Free subscription) | 9 hours ago
LANSING, Mich., Dec. 1 /PRNewswire-FirstCall/ -- Neogen Corporation (Nasdaq: NEOG) announced today that it has acquired the BioKits food safety business of San Diego, Calif.-based Gen-Probe Incorporated (Nasdaq: GPRO). The acquisition includes more than 50 test kits for food allergens, meat and fish speciation, and plant genetics.
4Vote!
PR News Wire (Free subscription) | 11/24/2009
SAN DIEGO, Nov. 24 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO) announced today that the US Food and Drug Administration (FDA) has cleared for marketing Prodesse's ProParaflu+(TM) assay, a molecular test that detects and differentiates parainfluenza 1, 2 and 3 viruses, which cause lower respiratory tract infections.
4Vote!
PR News Wire (Free subscription) | 11/16/2009
SAN DIEGO, Nov. 16 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO) announced today that the Company will webcast its annual meeting with institutional investors and financial analysts in New York on Thursday, December 3, 2009, at 9 a.m. Eastern Time (ET). The event will feature presentations on Gen-Probe's current business and future growth strategies by several Company executives....
4Vote!
PR News Wire (Free subscription) | 10/29/2009
SAN DIEGO, Calif., Oct. 29 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO) today reported financial results for the third quarter of 2009, with record product sales and total revenues driving non-GAAP earnings per share (EPS) of $0.47.
4Vote!
PR News Wire (Free subscription) | 10/29/2009
SAN DIEGO, Oct. 29 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO) today announced that the US Food and Drug Administration (FDA) has granted an EUA (emergency use authorization) for its test, the Prodesse ProFlu-ST(TM), to be used in CLIA high complexity laboratories for the diagnosis of 2009 H1N1 influenza virus infection, aided by an algorithm that relies on seasonal influenza A/H1...
4Vote!
Business Wire (Free subscription) | 10/12/2009
SAN DIEGO--(BUSINESS WIRE)--Gen-Probe Incorporated (NASDAQ: GPRO) announced today that the Company will release its third quarter 2009 financial results on Thursday, October 29, 2009 at approximately 4:00 p.m. Eastern Time (ET). The announcement will be followed by a conference call with management at 4:30 p.m. ET. The conference call will be webcast live and may be accessed on the investors section...
3Vote!
DeviceSpace (Free subscription) | 10/07/2009
SAN DIEGO, Oct. 6 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO - News) announced today that it has signed a definitive agreement to acquire Prodesse, Inc., a privately held leader in molecular testing for influenza and other infectious diseases, for approximately $60 million in cash. Gen-Probe's purchase price could increase to up to $85 million if Prodesse achieves certain financial...
4Vote!
PR News Wire (Free subscription) | 10/06/2009
SAN DIEGO, Oct. 6 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO) announced today that it has signed a definitive agreement to acquire Prodesse, Inc., a privately held leader in molecular testing for influenza and other infectious diseases, for approximately $60 million in cash. Gen-Probe's purchase price could increase to up to $85 million if Prodesse achieves certain financial and...
3Vote!
DeviceSpace (Free subscription) | 09/14/2009
SAN DIEGO, Sept. 14 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq:GPRO) announced today that it is spinning off its industrial testing assetsinto a new, independent company focused on developing rapid, highly accuratemolecular assays for biopharmaceutical production, water and food safetytesting, and other applications. Gen-Probe initially will own 19.9% of the new company...
4Vote!
Business Wire (Free subscription) | 09/14/2009
BILLERICA, Mass.--(BUSINESS WIRE)--Millipore Corporation (NYSE:MIL), a leading provider of technologies, tools and services for the global life science industry, today announced that it will collaborate with Roka Bioscience, Inc. to develop molecular assays and portable instruments for biopharmaceutical production. As recently announced by Gen-Probe Incorporated (NASDAQ: GPRO), Roka Bioscience is a...
5Vote!
Red Orbit (Free subscription) | 09/03/2009
SAN DIEGO, Sept. 3 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO) announced today that the Company will present at the following investor conferences: Baird's 2009 Health Care Conference in New York at 2:45 p.m.
3Vote!
DeviceSpace (Free subscription) | 08/28/2009
SAN DIEGO, Aug. 27 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO - News) announced today that the Company has begun a clinical trial intended to secure U.S. regulatory approval of its PROGENSA® PCA3 assay, a new molecular test that may help determine the need for a repeat prostate biopsy. "Based on the results of our extensive clinical research studies and our European commercial...
3Vote!
Medical News Today (Free subscription) | 08/18/2009
Gen-Probe Incorporated (Nasdaq: GPRO) announced that the Company has begun a clinical trial intended to secure U.S. regulatory approval of its APTIMA((R)) assay for Trichomonas vaginalis on the fully automated TIGRIS((R)) system.
5Vote!
Red Orbit (Free subscription) | 08/17/2009
SAN DIEGO, Aug. 17 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO) announced today that the Company has begun a clinical trial intended to secure U.S.
3Vote!
aarkstore | 07/22/2009
Summary Gen-Probe Incorporated (Gen-Probe) is engaged in the development, manufacture and marketing of nucleic acid tests (NATs), principally used to diagnose human diseases and screen donated human blood. The company principally operates in North America. It is headquartered in California, United States and employs 1,049 people. The company’s subsidiaries include Gen-Probe Sales & Service, Inc., Delaware;...